THBS1 was found to be a direct target of epigenetic suppression by the enhancer of zeste homolog 2 (EZH2), which can directly regulate THBS1, thereby promoting neuroendocrine progression and angiogenesis in invasive prostate cancer [44]. The gene discussed is THBS1; the disease is prostate carcinoma.